Two South Africans make an ultra-rapid screening test for the Covid-19.

Share on facebook
Share on twitter
Share on whatsapp
Daniel Ndima and Dineo Lioma

As part of the battle against Covid-19, South African entrepreneurs Daniel Ndima and Dineo Lioma of the company Cape Bio have designed a test that identifies the presence of a infection within the blood in just over an hour .

In the summer of 2020, up to 4 million coronavirus tests made by researchers financed by the British government and the Bill & Melinda Gates foundation are anticipated to be conveyed across the African continent.  However, this initiative will not be sufficient to stem the plague over the continent. Reliance on imported tests can unfortunately also delay their reception and the viability of anti-virus campaigns.

South Africa is far better off than the rest of the continent in the fight against Coronavirus, Covid-19. As of April 21, 2020, the number of people tested for the virus was over 120,000. However, this number is insufficient.

Most of the screening tests used in the country are also imported. In response to this problem, Daniel Ndima and Dineo Lioma, the managers of the company Cape Bio created qCPR, an innovative screening test.

An example of a coronavirus test kit

To begin with, its results comes about in 65 minutes. This delay is much shorter than that of other tests, which frequently give comes about in a few hours. In addition, made in South Africa, they will cost less and take less time to be distributed on the territory.

The quirk of Cape Bio within the African scene consists in designing enzymes, these principal substances for the examination of DNA. Daniel Ndima has been a researcher curious about structural biology for 12 years. Concurring to him, “patriotic obligation” which driven him to make qCPR.   A comparable patriotic feeling led Dineo Lioma, a graduate in metallurgical and materials engineering from the University of the Witwatersrand and in micro and nanotechnology commerce from the prestigious Cambridge University, to decline a doctoral offer in the latter.

Since then, Lioma has co-founded another company where she led the implementation of another HIV test, this time “I knew I wanted to work in the health sector and help Africa South to progress. There aren’t a lot of micro and nanotechnology here, so I came home. I wanted to give back, ”she said.

The test is expected to be distributed nationwide in June 2020.

Leave a Reply

Your email address will not be published. Required fields are marked *